Inventor · disambiguated record
Michael A. Eldon
Also filed as: ELDON MICHAEL · ELDON MICHAEL A
8 granted patents·7 pending applications·48 citations·filing 2003–2021
85Inventor score
Top patents by PatentIndex Score
15 records- 0189US7326691B2Compositions comprising amphotericin B, methods, and systemsNEKTAR THERAPEUTICS·Filed 2005·Granted Feb 5, 2008·14 cites·6 claims
- 0286US8900555B2Insulin derivative formulations for pulmonary deliveryKUO MEI-CHANG·Filed 2007·Granted Dec 2, 2014·14 cites·3 claims
- 0381US8404217B2Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and useTARARA THOMAS E·Filed 2005·Granted Mar 26, 2013·3 cites·21 claims
- 0480US8906353B2Compositions and methods for achieving sustained therapeutic drug concentrations in a subjectELDON MICHAEL A·Filed 2009·Granted Dec 9, 2014·8 cites·13 claims
- 0579US10525051B2Compositions and methods for achieving sustained therapeutic drug concentrations in a subjectNEKTAR THERAPEUTICS·Filed 2017·Granted Jan 7, 2020·3 cites·13 claims
- 0675US9801873B2Methods for treating humans having brain cancerNEKTAR THERAPEUTICS·Filed 2014·Granted Oct 31, 2017·3 cites·11 claims
- 0774US10132810B2Method for assessing and predicting efficacy of breast cancer treatment with a long-acting topoisomerase I inhibitorNEKTAR THERAPEUTICS·Filed 2013·Granted Nov 20, 2018·3 cites·17 claims
- 0865US11033631B2Methods of treating CYP2D6 alternative metabolizersELDON MICHAEL A·Filed 2009·Granted Jun 15, 2021·0 cites·9 claims
- 0958US2014363506A1Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and useNOVARTIS AG·Filed 2012·Application pending·0 cites
- 1057US2021401998A1Methods of treating cyp2d6 alternative metabolizersNEKTAR THERAPEUTICS·Filed 2021·Application pending·0 cites
- 1156US2019049450A1Method for Assessing and Predicting Efficacy of Breast Cancer Treatment with a Long-Acting Topoisomerase I InhibitorNEKTAR THERAPEUTICS·Filed 2018·Application pending·0 cites
- 1253US2004176391A1Aerosolizable pharmaceutical formulation for fungal infection therapyNEKTAR THERAPEUTICS·Filed 2003·Application pending·0 cites
- 1339US2006160871A1Stable non-crystalline formulation comprising losartanNEKTAR THERAPEUTICS·Filed 2005·Application pending·0 cites
- 1437US2021085672A1Oral tablet formulationsINHERIS BIOPHARMA INC·Filed 2018·Application pending·0 cites
- 1537US2014378404A1Treatment of Patients Suffering from CancerNEKTAR THERAPEUTICS·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael A. Eldon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →